Standout Papers

Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations 2023 2026 2024104
  1. Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations (2023)
    Éric Bouffet, Jordan R. Hansford et al. New England Journal of Medicine

Immediate Impact

56 standout
Sub-graph 1 of 23

Citing Papers

Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
2025 Standout
1 intermediate paper

Works of Ashley Plant being referenced

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations
2023 Standout

Author Peers

Author Last Decade Papers Cites
Ashley Plant 231 110 119 187 163 28 509
Zachary R. Barnard 145 117 131 109 233 28 541
Mark Pykett 120 66 155 105 122 21 512
Robert Aiken 196 37 217 114 189 36 551
Christopher E. Mandigo 135 59 109 116 100 23 448
Angela J. Waanders 155 99 206 49 106 39 455
Yukina Morimoto 188 103 120 108 120 32 458
George J. Snipes 96 102 145 63 88 22 457
Mariza Daras 141 42 166 54 166 37 456
Kellie B. Haworth 94 103 110 71 180 17 429
N. Riva 135 77 73 79 150 17 483

All Works

Loading papers...

Rankless by CCL
2026